Journal of Pharmacopuncture (대한약침학회지)

KOREAN PHARMACOPUNCTURE INSTITUTE (대한약침학회)
권호 표지
DOI QR코드

DOI QR Code

A Behavioral Study of Promethazine Interaction with Analgesic Effect of Diclofenac: Pain Combination Therapy

  • Amidi, Niloofar (Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences) ;
  • Izadidastenaei, Zohreh (Neurophysiology Research Center, Hamadan University of Medical Sciences) ;
  • Araghchian, Malihe (Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences) ;
  • Ahmadimoghaddam, Davoud (Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences)
  • Received : 2019.05.22
  • Accepted : 2020.02.03
  • Published : 2020.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Pain is considered as a cause of sickness and the most prevalent symptom which makes people visit a physician. Nowadays, combination therapy is becoming useful to relieve chronic and postsurgical pain. The aim of this study was to study the promethazine (as an antihistamine) interactions with antinociceptive effect of diclofenac (as a non-steroidal anti-inflammatory drugs). Methods: In initial part of the study, we investigate the analgesic effect of diclofenac. Using writhing test, we demonstrate that diclofenac significantly reduces writhe response induced by acetic acid in a dose-dependent manner. In this study, we evaluate the combination effect of promethazine on diclofenac analgesic effect. Results: We observed that diclofenac inhibited pain in the dose dependent manner which means that by increasing dose of diclofenac a significant decrease in pain was observed. This experimental setup allowed calculation of the dose that caused 50% antinociception (ED50) for diclofenac. The ED50 for diclofenac in this study was determined to be 9.1 mg/kg according our previous study. Additionally, promethazine was showed a dose-dependent inhibition of writhes. The combination of different doses of promethazine (2, 4, 6 mg / kg) with diclofenac ED50 (9.1 mg / kg) was injected to mice. Promethazine 4 and 6 mg / kg in combination with diclofenac had significantly led to increase analgesic effect of diclofenac. Conclusion: In conclusion, these results add important information to the existing knowledge on combination of diclofenac and antihistamine in pain therapies to be used in clinical practice and maybe helpful in designing the future guidelines.

Keywords

References

  1. Bennett RM, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. The American journal of medicine. 2003;114(7):537-45. https://doi.org/10.1016/S0002-9343(03)00116-5
  2. Backonja MM, G. Irving, C Argoff. Rational multidrug therapy in the treatment of neuropathic pain. Current pain and headache reports. 2006;10(1):34-8. https://doi.org/10.1007/s11916-006-0007-1
  3. Kerrick JM, et al. Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: a placebo-controlled trial. Pain. 1993;52(3):325-30. https://doi.org/10.1016/0304-3959(93)90166-M
  4. Gilron I, et al. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine. 2005;352(13):1324-34. https://doi.org/10.1056/NEJMoa042580
  5. Mao J, MS Gold. Combination drug therapy for chronic pain: a call for more clinical studies. The Journal of Pain. 2011;12(2):157-66. https://doi.org/10.1016/j.jpain.2010.07.006
  6. Nili-Ahmadabadi A, et al. The occurrence of acetaminophen/codeine as an adulterant in herbal analgesic supplements in Hamadan, Iran: A pilot study. Complementary therapies in medicine, 2019;42:223-5. https://doi.org/10.1016/j.ctim.2018.11.018
  7. Aghababaei R, et al. Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: a significant health challenge in drug abusers. DARU Journal of Pharmaceutical Sciences. 2018;26(1):77. https://doi.org/10.1007/s40199-018-0205-5
  8. Gan T.J., Diclofenac: an update on its mechanism of action and safety profile. Current medical research and opinion. 2010;26(7):1715-31. https://doi.org/10.1185/03007995.2010.486301
  9. Vellani, V., et al. Effects of NSAIDs and paracetamol (acetaminophen) on protein kinase C epsilon translocation and on substance P synthesis and release in cultured sensory neurons. Journal of pain research. 2013;6:111. https://doi.org/10.2147/JPR.S36916
  10. Knotkova H, M Pappagallo. Adjuvant analgesics. Anesthesiology clinics. 2007;25(4):775-86. https://doi.org/10.1016/j.anclin.2007.07.006
  11. Rumore MM, DA Schlichting. Clinical efficacy of antihistaminics as analgesics. Pain, 1986. 25(1): p. 7-22. https://doi.org/10.1016/0304-3959(86)90004-7
  12. Ashmawi HA, et al. Analgesic effects of H1 receptor antagonists in the rat model of formalin-induced pain. Brazilian Journal of Anesthesiology. 2009;59(4):461-70. https://doi.org/10.1590/S0034-70942009000400008
  13. Santiago-Palma J, et al. Diphenhydramine as an analgesic adjuvant in refractory cancer pain. Journal of pain and symptom management. 2001;22(2):699-703. https://doi.org/10.1016/S0885-3924(01)00311-6
  14. Stevens CW, DN MacIver, LC Newman. Testing and comparison of non-opioid analgesics in amphibians. Journal of the American Association for Laboratory Animal Science. 2001;40(4):23-7.
  15. Asadollahi S, et al. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial. Headache: The Journal of Head and Face Pain, 2014;54(1):94-108. https://doi.org/10.1111/head.12259
  16. Raffa R. Antihistamines as analgesics. Journal of clinical pharmacy and therapeutics. 2001;26(2): 81-5. https://doi.org/10.1046/j.1365-2710.2001.00330.x
  17. Jaaskelainen SK, et al. Role of the dopaminergic system in chronic pain-a fluorodopa-PET study. Pain, 2001;90(3):257-60. https://doi.org/10.1016/s0304-3959(00)00409-7
  18. Schrepf A, et al. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain. 2016;157(10):2217. https://doi.org/10.1097/j.pain.0000000000000633
  19. Sommer C. Serotonin in pain and analgesia. Molecular neurobiology. 2004;30(2):117-25. https://doi.org/10.1385/MN:30:2:117
  20. Picazo A, G Castaneda-Hernandez, MI Ortiz. Examination of the interaction between peripheral diclofenac and gabapentin on the 5% formalin test in rats. Life sciences. 2006;79(24):2283-7. https://doi.org/10.1016/j.lfs.2006.07.025
  21. Miranda HF, F Sierralta, G Pinardi. An isobolographic analysis of the adrenergic modulation of diclofenac antinociception. Anesthesia & Analgesia. 2001;93(2):430-5. https://doi.org/10.1213/00000539-200108000-00039
  22. Zeraati F, M Araghchian, MH Farjoo. Ascorbic Acid interaction with analgesic effect of morphine and tramadol in mice. Anesthesiology and pain medicine. 2014;4(3).
  23. Zhang L, et al. Anti-inflammatory and analgesic effects of ethanol and aqueous extracts of Pterocephalus hookeri (CB Clarke) Hoeck. Journal of ethnopharmacology. 2009;123(3):510-4. https://doi.org/10.1016/j.jep.2009.01.039
  24. Gannon WL, RS Sikes. Guidelines of the American Society of Mammalogists for the use of wild mammals in research. Journal of Mammalogy. 2007;88(3):809-23. https://doi.org/10.1644/06-MAMM-F-185R1.1
  25. Ayoub SS, et al. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol. 2006;538(1-3):57-65. https://doi.org/10.1016/j.ejphar.2006.03.061
  26. Farshchi A, et al. Antinociceptive effect of promethazine in mice. Iranian Journal of Basic Medical Sciences. 2009;12(3):140-5.
  27. Pinheiro MM, et al. Antinociceptive activity of fractions from Couroupita guianensis Aubl. leaves. Journal of ethnopharmacology. 2010;127(2):407-13. https://doi.org/10.1016/j.jep.2009.10.025
  28. Santos AR, et al. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology. 2005;48(7):1021-34. https://doi.org/10.1016/j.neuropharm.2005.01.012
  29. Zasso FB, et al. On the mechanisms involved in antinociception induced by diphenyl diselenide. Environmental toxicology and pharmacology. 2005;19(2):283-9. https://doi.org/10.1016/j.etap.2004.08.003
  30. Mobarakeh JI, et al. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice. Neuropharmacology. 2006;51(3):612-22. https://doi.org/10.1016/j.neuropharm.2006.05.003
  31. Tamaddonfard E, et al. Central effect of histamine in a rat model of acute trigeminal pain. Pharmacological Reports. 2008;60(2):219.
  32. Galeotti N, C Ghelardini, A Bartolini. The role of potassium channels in antihistamine analgesia. Neuropharmacology. 1999;38(12):1893-1901. https://doi.org/10.1016/S0028-3908(99)00068-4
  33. De Paz-Campos MA, et al. Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats. Phytomedicine. 2014;21(12):1543-8. https://doi.org/10.1016/j.phymed.2014.06.015
  34. Rios L, JJ Jacob. Local inhibition of inflammatory pain by naloxone and its N-methyl quarternary analogue. European journal of pharmacology. 1983;96(3-4):277-83. https://doi.org/10.1016/0014-2999(83)90317-5
  35. Tsuruoka M, et al. Effects of yohimbine on naloxone-induced antinociception in a rat model of inflammatory hyperalgesia. European journal of pharmacology. 1998;348(2):161-5. https://doi.org/10.1016/S0014-2999(98)00151-4
  36. Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetarmol. Acta Anaesthesiologica Scandinavica. 1995;39(s103):7-44. https://doi.org/10.1111/j.1399-6576.1995.tb04249.x
  37. Pernia-Andrade AJ, V Tortorici, H Vanegas. Induction of opioid tolerance by lysine-acetylsalicylate in rats. Pain. 2004;111(1):191-200. https://doi.org/10.1016/j.pain.2004.06.006
  38. Madenoglu H, et al. Effects of naloxone and flumazenil on antinociceptive action of acetaminophen in rats. Current Therapeutic Research. 2010;71(2):111-7. https://doi.org/10.1016/j.curtheres.2010.03.001
  39. Dharmshaktu P, V Tayal, BS Kalra. Efficacy of antidepressants as analgesics: a review. The Journal of Clinical Pharmacology. 2012;52(1):6-17. https://doi.org/10.1177/0091270010394852
  40. Zeitz KP, et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. The Journal of neuroscience. 2002. 22(3):1010-9. https://doi.org/10.1523/jneurosci.22-03-01010.2002
  41. Mallet C, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain, 2008. 139(1):190-200. https://doi.org/10.1016/j.pain.2008.03.030
  42. Groppetti A, et al. Effect of aspirin on serotonin and met-enkephalin in brain: correlation with the antinociceptive activity of the drug. Neuropharmacology. 1988;27(5):499-505. https://doi.org/10.1016/0028-3908(88)90132-3
  43. Pinardi G, F Sierralta, H Miranda. Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice. Pharmacology Biochemistry and Behavior. 2003;74(3):603-8. https://doi.org/10.1016/S0091-3057(02)01046-8
  44. Katyal J, YK Gupta. Dopamine release is involved in antinociceptive effect of theophylline. International Journal of Neuroscience. 2012;122(1):17-21. https://doi.org/10.3109/00207454.2011.613550